Recon: UK approves fifth COVID vaccine with Novavax approval; Lilly delays timeline for submitting Alzheimer’s drug application

Recon

ReconJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy